|
Variable
| |
Mean ± SD
|
Mean difference between groups at baseline and at 12-weeks (95% CI)
|
PValue
|
Cohen's d
|
|---|
| |
N
|
LPA
|
FME
| | | |
|---|
|
FM impact questionnaire
| | | | | | |
|
Baseline
|
84
|
67.5 ± 12.0
|
69.7 ± 13.4
|
2.2 (-3.3 to 7.8)
|
0.424
|
.17
|
|
Post intervention
|
73
|
56.7 ± 20.6
|
67.0 ± 18.6
|
10.2 (.91 to 19.6)
|
0.032
|
.53
|
|
Pain
| | | | | | |
|
Baseline
|
84
|
54.6 ± 25.6
|
58.9 ± 25.0
|
4.3 (-7.2 to 14.9)
|
0.489
|
.17
|
|
Post intervention
|
73
|
46.3 ± 24.2
|
62.4 ± 24.5
|
16.1 (4.6 to 27.5)
|
0.006
|
.67
|
|
Fatigue severity scale
| | | | | | |
|
Baseline
|
84
|
51.9 ± 9.3
|
52.3 ± 9.1
|
.4 (-3.6 to 4.4)
|
0.843
|
.04
|
|
Post intervention
|
73
|
50.6 ± 9.9
|
51.4 ± 10.1
|
.8 (-3.9 to 5.5)
|
0.727
|
.07
|
|
CES-D*
| | | | | | |
|
Baseline
|
84
|
23.4 ± 8.6
|
24.0 ± 10
|
.6 (-3.8 to 4.5)
|
0.798
|
.06
|
|
Post intervention
|
73
|
21.6 ± 9.8
|
21.2 ± 11.3
|
.4 (-5.3 to 4.6)
|
0.888
|
.04
|
|
Number of tender points
| | | | | | |
|
Baseline
|
84
|
16.2 ± 2.3
|
16.1 ± 3.2
|
.1 (-1.2 to 1.0)
|
0.979
|
.03
|
|
Post intervention
|
72
|
16.0 ± 2.3
|
16.8 ± 2.0
|
.8 (-.35 to 1.9)
|
0.172
|
.37
|
|
Body mass index (BMI)
| | | | | | |
|
Baseline
|
82
|
31.4 ± 8.4
|
29.8 ± 6.2
|
1.6 (-4.7 to 1.7)
|
0.360
|
.22
|
|
Post intervention
|
60
|
31.0 ± 9.0
|
29.9 ± 6.2
|
1.1 (-5.3 to 2.9)
|
0.575
|
.14
|
|
Six-minute walk test, yd/sec
| | | | | | |
|
Baseline
|
77
|
1.08 ± 0.15
|
1.08 ± 0.19
|
.0004 (-0.78 to 0.79)
|
0.991
|
0
|
|
Post intervention
|
62
|
1.24 ± 0.28
|
1.11 ± 0.20
|
1.21 (-0.25 to 0.008)
|
0.067
|
.53
|
- * Center for Epidemiologic Studies Depression Scale; a between-subjects t-tests were used to derive P values; bCohen's d [19] effect size estimates (d = .20 (small effect); d = .50 (medium effect); d = .80 (large effect)).
- FME, fibromyalgia education; LPA, lifestyle physical activity
